高级检索
当前位置: 首页 > 详情页

Anticancer activity of sugiol against ovarian cancer cell line SKOV3 involves mitochondrial apoptosis, cell cycle arrest and blocking of the RAF/MEK/ERK signalling pathway.

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of Gynaecology, Hubei Maternity and Child Health Hospital, Wuhan, China [2]Department of Obstetrics and Gynaecology, Beijing Hospital, Beijing, China [3]Department of Obstetrics and Gynaecology, Haidian Woman’s and Children’s Hospital, Beijing, China [4]Department of Obstetrics and Gynaecology, Dongguan Hospital of Traditional Chinese Medicine, Dongguan Guangdong, China
出处:
ISSN:

关键词: ovarian cancer cell cycle arrest apoptosis RAF/MEK/ERK cell migration

摘要:
Ovarian cancer is one of the leading causes of cancer-related deaths in women. Treatments for ovarian cancer include surgery followed by chemotherapy. However, the survival rate for ovarian cancer is still not satisfactory. Moreover, the current chemotherapy has numerous associated side effects. Therefore there is an urgent need to look for novel and more viable treatment options. Against this backdrop the present study was designed to evaluate the anticancer activity of sugiol against ovarian cancer cells. Cell viability was assessed by CCK8 assay, apoptosis by DAPI, AO/ER and annexin V/PI staining. Mitochondrial membrane potential and cell cycle analysis was performed by flow cytometry. Cell migration was investigated by wound healing assay. Protein expression was monitored by western blotting. The results of the present study indicated that sugiol exerts significant (p < 0.0001) anticancer effects on SKOV3 cancer cells with an IC50 of 25 μM. However, sugiol exhibited less cytotoxicity against normal ovarian cells with an IC50 of 62.5 μM. The anticancer effects of sugiol were found to be due to G0/G1 cell cycle arrest and mitochondrial apoptosis. Sugiol also inhibited cell migration of SKOV3 cells dose dependently. Moreover, the results showed that sugiol could inhibit the RAF/MEK/ERK signalling pathway in a dose-dependent manner. The results of the present study indicate that sugiol exerts potent anticancer effects on SKOV3 cells via induction of cell cycle arrest, mitochondrial apoptosis and inhibition of the RAF/MEK/ERK signalling pathway. Copyright: © 2017 Termedia & Banach.

语种:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 4 区 医学
小类 | 3 区 医学:内科
最新[2025]版:
大类 | 4 区 医学
小类 | 3 区 医学:内科
第一作者:
第一作者机构: [1]Department of Gynaecology, Hubei Maternity and Child Health Hospital, Wuhan, China
通讯作者:
通讯机构: [2]Department of Obstetrics and Gynaecology, Beijing Hospital, Beijing, China [*1]Department of Obstetrics and Gynaecology, Beijing Hospital, 1 Dongdan Dahua Road, 100730 Beijing, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号